Currently Viewing:
ACO & Emerging Healthcare Delivery Coalition® Spring 2017
Currently Reading
Michael Griffin on How AHCA Affects Patients in New Orleans
May 04, 2017
Difficult, but Rewarding Work of Public-Private Partnerships to Address Health Issues
May 05, 2017
Lee Barrett Discusses Keeping Protected Health Information Safe
May 05, 2017
Dr Clifford Goodman Highlights a Key Takeaway From the Spring 2017 Meeting of the ACO Coalition
May 06, 2017
Finding Value of Life-Saving Therapies Can Reveal What Matters to Patients
May 06, 2017
Healthcare Reform Needs to Improve Access to Care, Panelists Say
May 06, 2017
As 2020 Nears, Addressing Needs Beyond Clinic Walls Rises on the Healthcare Radar
May 06, 2017
Dr Sachin Jain: Taking Care of Patients in the Context of Their Lives
May 09, 2017
Lee Barrett Explains How Abundance of Health Data Increases Risk of Breaches
May 26, 2017
Michael Griffin's Health Policy Suggestion: Medicaid For All
May 27, 2017
Dr Clifford Goodman: Why Focus on Value Will Persist Regardless of Changing Legislation
May 29, 2017
Dr Sachin Jain: Discussion on Population Health Reveals Causes for Optimism
June 01, 2017
Dr Clifford Goodman on What to Look Forward to at the Fall 2017 ACO Coalition Meeting
June 09, 2017
Lee Barrett on the Balance Between Strong Cybersecurity and Patient Access to Data
June 13, 2017
Dr Sachin Jain Focuses on Bipartisan Healthcare Efforts, Not Policy Changes
June 15, 2017
Dr Clifford Goodman Discusses Evidence-Based Drug Pricing as an Alternative to Legislative Controls
June 21, 2017
Michael Griffin: Katrina's Lasting Effects on New Orleans and Its Healthcare System
June 22, 2017
Lee Barrett: Increased Data Exchange in Value-Based Models Poses Cybersecurity Risks
June 29, 2017
Michael Griffin Discusses Daughters of Charity's Ongoing Technology Initiatives
July 03, 2017
Dr Sachin Jain on CareMore's Mission to Manage Chronic Disease From the Dentist's Chair
July 08, 2017
Dr Clifford Goodman on Possible Drug Pricing Solutions Adapted From Abroad
July 11, 2017
Michael Griffin on Aligning Payers With Population Health and Social Determinants
July 12, 2017
Lee Barrett Outlines Best Practices for Healthcare Cybersecurity
July 15, 2017
Dr Sachin Jain Discusses CareMore's Community Partnerships, Internal Programs
July 18, 2017

Dr Darius Lakdawalla Discusses the Meaning and Measure of "Value" in Healthcare

The perspective of the decision maker in healthcare affects the meaning of value and the US healthcare system is still trying to figure out how to measure value, said Darius Lakdawalla, PhD, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation at the School of Pharmacy at the University of Southern California.


The perspective of the decision maker in healthcare affects the meaning of value and the US healthcare system is still trying to figure out how to measure value, said Darius Lakdawalla, PhD, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation at the School of Pharmacy at the University of Southern California.

Transcript (slightly modified)

In what ways does the idea of “value” vary, and how can the healthcare industry bridge the gap?

Value depends on several factors that vary. One is just the perspective of the decision maker, so value to an employer, for instance, may be very different than value to an insurance company. The employer might worry about the number of sick days, how productive its employees are, how healthcare affects that productivity. The payer might be focused on things like the medical costs, the prescription drug costs, the direct health benefits, and may be less concerned about things that the patient cares about, like the burden on family members for care.

So, value is going to generally incorporate different aspects depending on the perspective of the decision maker involved.

The number of value frameworks is growing, but are they being used yet in meaningful ways?

I think that right now we are in a situation where we are trying to figure out how to measure value. I think there is a lot of controversy over how to measure value and we see that in all of the debates about what value frameworks to use and how to construct value frameworks. I think actually, that the bigger question here is: how do you bring value into the marketplace?

Even if we magically figured out tomorrow how to solve all of these measurement problems, it’s still not 100% clear what we would do next. Would we hand those numbers over to a new federal agency to regulate prices? Would we somehow use those numbers in the marketplace to help decision makers make price decisions that are more aligned with value? No one really knows and I think we need to begin to work on that problem if we are ultimately going to make an impact on value in healthcare more generally. 

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up